JP2023519853A5 - - Google Patents
Info
- Publication number
- JP2023519853A5 JP2023519853A5 JP2022558100A JP2022558100A JP2023519853A5 JP 2023519853 A5 JP2023519853 A5 JP 2023519853A5 JP 2022558100 A JP2022558100 A JP 2022558100A JP 2022558100 A JP2022558100 A JP 2022558100A JP 2023519853 A5 JP2023519853 A5 JP 2023519853A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- rtx
- inflammatory
- pneumonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026000517A JP2026042884A (ja) | 2020-03-30 | 2026-01-05 | レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002165P | 2020-03-30 | 2020-03-30 | |
| US63/002,165 | 2020-03-30 | ||
| US202063122858P | 2020-12-08 | 2020-12-08 | |
| US63/122,858 | 2020-12-08 | ||
| PCT/US2021/022089 WO2021202084A1 (en) | 2020-03-30 | 2021-03-12 | Treating pulmonary inflammatory disease associated with covid-19 by administering resiniferatoxin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026000517A Division JP2026042884A (ja) | 2020-03-30 | 2026-01-05 | レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519853A JP2023519853A (ja) | 2023-05-15 |
| JP2023519853A5 true JP2023519853A5 (https=) | 2024-03-22 |
Family
ID=75340289
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558100A Pending JP2023519853A (ja) | 2020-03-30 | 2021-03-12 | レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置 |
| JP2026000517A Pending JP2026042884A (ja) | 2020-03-30 | 2026-01-05 | レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026000517A Pending JP2026042884A (ja) | 2020-03-30 | 2026-01-05 | レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230143545A1 (https=) |
| EP (1) | EP4125871A1 (https=) |
| JP (2) | JP2023519853A (https=) |
| KR (1) | KR20220161423A (https=) |
| CN (1) | CN115666551A (https=) |
| AU (1) | AU2021248861A1 (https=) |
| CA (1) | CA3173611A1 (https=) |
| WO (1) | WO2021202084A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300072A (en) * | 2020-08-11 | 2023-03-01 | Sorrento Therapeutics Inc | Treatment of pneumonia by nerve ablation |
| WO2025153517A1 (en) | 2024-01-15 | 2025-07-24 | Grünenthal GmbH | Treating knee joint pain by injecting resiniferatoxin at ultra low doses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2187193B (en) | 1986-02-27 | 1989-11-08 | Gerald Scott | Controllably and swiftly degradable polymer compositions and films and other products made therefrom |
| US5021450A (en) | 1989-05-30 | 1991-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| US5232684A (en) | 1990-06-29 | 1993-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Labelled resiniferatoxin, compositions thereof, and methods for using the same |
| GB9826359D0 (en) * | 1998-12-01 | 1999-01-27 | Glaxo Group Ltd | Novel receptors |
| CA2880855A1 (en) | 2012-08-03 | 2014-02-06 | Mestex Ag | Resiniferatoxin solution |
| EP3131541A4 (en) * | 2014-04-14 | 2018-02-14 | Flex Pharma, Inc. | Ion channel activators and methods of use |
| US20200129472A1 (en) * | 2017-02-09 | 2020-04-30 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the treatment of peripheral artery disease |
| MX2020002692A (es) * | 2017-09-11 | 2020-10-14 | Sorrento Therapeutics Inc | Formulacion de resiniferatoxina. |
-
2021
- 2021-03-12 CN CN202180025683.4A patent/CN115666551A/zh active Pending
- 2021-03-12 WO PCT/US2021/022089 patent/WO2021202084A1/en not_active Ceased
- 2021-03-12 US US17/915,444 patent/US20230143545A1/en active Pending
- 2021-03-12 AU AU2021248861A patent/AU2021248861A1/en not_active Abandoned
- 2021-03-12 EP EP21716045.6A patent/EP4125871A1/en active Pending
- 2021-03-12 KR KR1020227037621A patent/KR20220161423A/ko not_active Ceased
- 2021-03-12 JP JP2022558100A patent/JP2023519853A/ja active Pending
- 2021-03-12 CA CA3173611A patent/CA3173611A1/en active Pending
-
2026
- 2026-01-05 JP JP2026000517A patent/JP2026042884A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI106433B (fi) | Menetelmä farmaseuttisen formulaation valmistamiseksi, joka soveltuu granulosyyttipesäkkeitä stimuloivan tekijän antamiseen keuhkojen kautta | |
| US20080167230A1 (en) | Methods and compositions for treating or preventing lesions of the respiratory epithelium | |
| US20090227511A1 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| US20230201497A1 (en) | Method for pulsatile delivery of a gaseous drug | |
| JP2023519853A5 (https=) | ||
| JP2002532520A (ja) | 気道病治療および気道用薬剤送達のための化合物および方法 | |
| CN110062625A (zh) | 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法 | |
| US20060134008A1 (en) | Compositions and methods for pulmonary conditions | |
| JP2003531867A (ja) | 抗体および抗炎症薬を用いた呼吸器疾患の組合せ治療法 | |
| AU2020226339A2 (en) | Methods of treatment of respiratory disorders | |
| JP2021520396A5 (https=) | ||
| JP2023537515A5 (https=) | ||
| CA3173611A1 (en) | Treating pulmonary inflammatory disease associated with covid-19 by administering resiniferatoxin | |
| CA3188689A1 (en) | Treating pulmonary inflammatory disease by neural ablation | |
| HUP0303755A2 (hu) | Szalmeterol és flutikaszon-propionát kombináció alkalmazása és ezt tartalmazó gyógyszerkészítmény | |
| WO2012142367A2 (en) | Compositions and methods for treatment of pulmonary diseases and conditions | |
| RU2417083C2 (ru) | Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний | |
| JP2023538125A5 (https=) | ||
| US20180110774A1 (en) | Compositions and methods for treatment of pulmonary hypertension | |
| CA2928736A1 (en) | Inhaled aerosolized immuno-chemotherapy for the treatment of mdr tb | |
| JP6021952B2 (ja) | 慢性閉塞性肺疾患の治療法 | |
| JP2022531920A (ja) | 薬剤性肺炎の治療に使用するための血管作動性腸管ペプチド（ｖｉｐ） | |
| FI3723790T3 (fi) | Menetelmiä immuunitoleranssin indusoimiseksi ja lääkevasta-ainevasteen vähentämiseksi | |
| Sethi et al. | Evidence based treatment of bronchiolitis | |
| US11197851B2 (en) | Methods of treatment of asthma and COPD |